DEC 07, 2020 8:32 AM PST

Black women with breast cancer have higher rates of mortality and comorbidities

New research published today the American Cancer Society’s peer-reviewed journal, Cancer, looks at the mortality rates of women with breast cancer, finding that Black women had higher rates of comorbidities such as obesity when compared to white women. This finding amplifies previous studies that have evidenced the gap in healthy equities between races in women fighting breast cancer.

"Early breast cancer is highly treatable, and survival rates have improved steadily due to treatment advances and early detection through mammograms; however, the high rates of obesity, overall comorbidities, and obesity-related comorbidities observed among women with early breast cancer--especially among Black women--can contribute to disparities in overall survival of these patients," commented Dr. Kirsten Nyrop, of the University of North Carolina at Chapel Hill. "Findings from this study need to be considered within the larger context of the cancer-obesity link and the disparate impact of the obesity epidemic on communities of color in the United States."

Dr. Nyrop and her team concluded this information by conducting an analysis of 548 patients treated for early breast cancer. Of these patients, the team noted that 62% of Black patients and 33% of white patients had weights classified as obese; within these groups, Black women had greater numbers of comorbidities like diabetes, hypertension, and high cholesterol than white women. The correlation between obesity and cancer has been well-documented over the last few decades and is considered a significant risk factor for several cancer types.

"As the COVID-19 pandemic has glaringly underscored, there is an urgent need to address the systemic and socioeconomic aspects of obesity that disproportionately affect minority communities in the U.S. if we are to reverse health disparities," comments Dr. Nyrop, explaining that many obesity-related cancers have a higher incidence in Black women than white women.

While this news is obviously a wake-up call for the many ways in which systemic racism weaves its injustices into our systems, medical systems included, the findings also offer an opportunity: breast cancer diagnoses and subsequent follow-up may provide the opening for physicians to implement interventions not only cancer-related but also related to comorbidities. As the authors observe, certain lifestyle interventions could be multi-faceted in their intentions.  

Sources: Cancer, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
APR 07, 2021
Cancer
Does inhibiting NLRP3 inhibit melanoma tumor growth?
APR 07, 2021
Does inhibiting NLRP3 inhibit melanoma tumor growth?
Researchers at the University of Colorado Cancer Center have published exciting findings in the Proceedings of the Natio ...
MAY 31, 2021
Immunology
Engineering Faster, More Agile T Cell Cancer Fighters
MAY 31, 2021
Engineering Faster, More Agile T Cell Cancer Fighters
Cell therapies use engineered T cells extracted from the patient’s own immune system to rally an attack on tumors. ...
JUN 07, 2021
Cell & Molecular Biology
Overcoming Challenges to Detect Apoptosis in 3D Cell Structures
JUN 07, 2021
Overcoming Challenges to Detect Apoptosis in 3D Cell Structures
Researchers are increasingly relying on cells grown in three-dimensional (3D) structures to help answer their research q ...
JUN 09, 2021
Clinical & Molecular DX
Faster, Cheaper Diagnosis of Rare Cancer in Fat Cells
JUN 09, 2021
Faster, Cheaper Diagnosis of Rare Cancer in Fat Cells
Scientists have created a gene panel test to quickly and more precisely diagnose common forms of liposarcoma. This break ...
JUN 11, 2021
Cell & Molecular Biology
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
JUN 11, 2021
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
The immune system can detect and destroy pathogenic and cancerous cells, but sometimes those dangerous cells can evade t ...
JUL 13, 2021
Clinical & Molecular DX
Friend or Foe? New Cancer-Tracking Pen Guides Surgeons.
JUL 13, 2021
Friend or Foe? New Cancer-Tracking Pen Guides Surgeons.
Researchers have developed the first diagnostic “pen” that acts as a guide for surgeons, helping them distin ...
Loading Comments...